STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMA
  4. [8-K] ImageneBio, Inc. Reports Material Event

Imagenebio (NASDAQ: IMA) finance chief Robert Lally to step down

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Imagenebio, Inc. reported that Robert Lally, its Senior Vice President of Finance and Operations and principal accounting officer, has resigned. He notified the company on June 22, 2026, and his resignation will be effective July 22, 2026. The company stated that his departure is not due to any disagreement with Imagenebio. Management plans to conduct a search for his replacement.

Positive

  • None.

Negative

  • None.
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Resignation notice date June 22, 2026 Date Robert Lally notified the company
Resignation effective date July 22, 2026 Date Robert Lally’s resignation becomes effective
Company address ZIP code 92130 San Diego, California principal executive offices ZIP code
Company phone number (858) 345-6265 Registrant’s telephone number
Trading symbol IMA Common Stock on The Nasdaq Capital Market
principal accounting officer financial
"Senior Vice President of Finance and Operations and principal accounting officer, provided notice of his resignation"
The Principal Accounting Officer is the person responsible for making sure a company's financial records are accurate and follow the rules. They play a key role in preparing financial reports that show how well the company is doing. This helps investors, managers, and regulators trust the company's financial information.
emerging growth company regulatory
"Emerging growth company    On June 22, 2026, Robert Lally, our Senior Vice President"
An emerging growth company is a recently public or smaller public firm that qualifies for temporary, lighter regulatory and disclosure rules to reduce the cost and effort of being public. For investors, it means the company may provide less historical financial detail and face fewer reporting requirements than larger firms, so it can grow more quickly but also carries higher uncertainty—like buying a promising early-stage product with fewer user reviews.
Nasdaq Capital Market market
"Common Stock, $0.001 par value | | IMA | | The Nasdaq Capital Market"
The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →
NASDAQ false 0001835579 0001835579 2026-06-22 2026-06-22
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 22, 2026

 

 

IMAGENEBIO, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-40287   81-1697316

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

 

12526 High Bluff Drive, Suite 345  
San Diego, California   92130
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (858) 345-6265

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 par value   IMA   The Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On June 22, 2026, Robert Lally, our Senior Vice President of Finance and Operations and principal accounting officer, provided notice of his resignation, effective July 22, 2026. Mr. Lally’s resignation was not due to any disagreement with the Company. We plan to conduct a search for Mr. Lally’s replacement.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    IMAGENEBIO, INC.
Date: June 26, 2026     By:  

/s/ Kristin Yarema

      Kristin Yarema, Ph.D.
      Chief Executive Officer

Source: View Original Filing on SEC EDGAR

FAQ

What leadership change did Imagenebio (IMA) disclose in this Form 8-K?

Imagenebio disclosed that Robert Lally, Senior Vice President of Finance and Operations and principal accounting officer, has resigned. He informed the company on June 22, 2026, and his resignation will be effective July 22, 2026, prompting a search for his replacement.

When is Robert Lally’s resignation from Imagenebio (IMA) effective?

Robert Lally’s resignation from Imagenebio is effective July 22, 2026. He provided notice to the company on June 22, 2026, allowing a one-month transition period while the company begins a search for his successor in the finance and operations role.

What position did Robert Lally hold at Imagenebio (IMA) before resigning?

Before resigning, Robert Lally served as Senior Vice President of Finance and Operations and principal accounting officer at Imagenebio. This combined role covered finance leadership and responsibility for the company’s accounting function, according to the Form 8-K disclosure text.

How does Imagenebio (IMA) plan to respond to the finance executive’s resignation?

Imagenebio plans to conduct a search for Robert Lally’s replacement following his resignation. The filing indicates the company will seek a new senior leader for finance and operations, including the principal accounting officer responsibilities, after his July 22, 2026 effective departure date.

Filing Exhibits & Attachments

3 documents

Other Documents